Invitra WJ-C™ is a minimally manipulated human tissue allograft suspension derived from the Wharton’s Jelly of the umbilical cord. Invitrx Therapeutics utilizes a proprietary process to preserve the growth and other native components on the Wharton’s Jelly for homologous use.
The umbilical cord, often considered the cord of life, is largely composed of Wharton’s Jelly. This gelatinous, structural tissue consists of structural proteins and components, such as collagen and hyaluronic acid, which work together to dampen the physical stresses during development. The tissue is also an abundant source of mesenchymal stem cells that are captured during fetal development and a rich source of developmental cytokines, chemokines, and growth factors.
Invitra WJ-C™ is processed from donated umbilical cords from full term deliveries. All donors are pre-screened and undergo comprehensive testing that includes:
- Behavioral risk assessment
- Physical assessment
- Donor medical history
- Communicable disease testing